Re­lo­cat­ing its US HQ to Boston, French phar­ma Ipsen to add 250 jobs

Boston’s biotech hub has at­tract­ed yet an­oth­er HQ, as French phar­ma com­pa­ny Ipsen said Thurs­day it will re­lo­cate its US op­er­a­tions from New Jer­sey to Kendall Square.

The com­pa­ny an­nounced the move on the last day of the BIO In­ter­na­tion­al Con­ven­tion, promis­ing to add 250 new jobs with the ex­pan­sion of its Boston pres­ence. Ipsen, which has a $11.2 bil­lion mar­ket cap, al­ready opened two out­posts in the city back in 2015: a com­mer­cial/man­u­fac­tur­ing site at One Kendall Square and an R&D site at 650 East Kendall St. Now, it’s mov­ing all 150 of its Boston em­ploy­ees in­to the East Kendall lo­ca­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER